Euro-Med Laboratories Phil., Inc. (PSE:EURO)

Market Cap	3.62B
Revenue (ttm)	6.26B
Net Income (ttm)	360.07M
Shares Out	4.11B
EPS (ttm)	0.09
PE Ratio	10.05
Forward PE	n/a
Dividend	0.06 (6.82%)
Ex-Dividend Date	n/a

Volume	11,000
Average Volume	39,850
Open	0.8800
Previous Close	0.8800
Day's Range	0.8800 - 0.8800
52-Week Range	0.7100 - 1.0100
Beta	0.25
RSI	45.53
Earnings Date	Aug 12, 2025

About United States Steel

Euro-Med Laboratories Phil., Inc. manufactures and sells various pharmaceutical products in the Philippines and internationally. It manufactures and distributes large and small volume parenterals that are used as solvents for other drugs; sterile water for injection; and other solutions for ophthalmic, inhalation, irrigation, and dialysis. The company also offers specialty fluids comprising dialysis solutions for the treatment of acute or chronic renal failure; hemodialysis solution, a concentrated solution of electrolytes in water for injectio...

• Industry: Pharmaceuticals
• Sector: Healthcare
• Founded: 1988
• Employees: 1,718
• Stock Exchange: Philippine Stock Exchange
• Ticker Symbol: EURO

Financial Performance

In 2024, PSE:EURO's revenue was 5.80 billion, an increase of 10.11% compared to the previous year's 5.26 billion. Earnings were 337.68 million, an increase of 16.46%.